Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
Titel:
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
Auteur:
Bennouna, Jaafar Girard, Nicolas Audigier-Valette, Clarisse le Thuaut, Aurélie Gervais, Radj Masson, Philippe Marcq, Marie Molinier, Olivier Cortot, Alexis Debieuvre, Didier Cadranel, Jacques Lena, Hervé Moro-Sibilot, Denis Chouaid, Christos Mennecier, Bertrand Urban, Thierry Sagan, Christine Perrier, Ludivine Barlesi, Fabrice Denis, Marc G.